Evidence
Addict Sci Clin Pract. 2023 Aug 17;18(1):49. doi: 10.1186/s13722-023-00405-x.
ABSTRACT
BACKGROUND: A valid opioid use disorder (OUD) identification algorithm for use in administrative medical record data would enhance investigators’ ability to study consequences of OUD, OUD treatment seeking and treatment outcomes.
MAIN BODY: Existing studies indicate ICD-9 and ICD-10 codes for opioid abuse and dependence do not accurately measure OUD. However, critical appraisal of existing literature suggests alternative validation methods would improve the validity of OUD identification algorithms in administrative data. Chart abstraction may not be sufficient to validate OUD, and primary data collection via structured diagnostic interviews might be an ideal gold standard.
CONCLUSION AND COMMENTARY: Generating valid OUD identification algorithms is critical for OUD research and quality measurement in real world health care settings.
PMID:37592369 | DOI:10.1186/s13722-023-00405-x
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Validating opioid use disorder diagnoses in administrative data: a commentary on existing evidence and future directions
🌐 90 Days
VR Related Evidence Matrix
- Association between opioid use disorder and palliative care: a cohort study using linked health administrative data in Ontario, Canada
- Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder
- Shaping and shifting schemas on supervised injectable opioid treatment: findings from a cross-sectional qualitative study in two German treatment facilities
- Assessing men with opioid use disorder for testosterone deficiency after the development of symptoms
- Pain and its Perceived Relatedness to the Onset, Maintenance, and Relapse of Opioid use Disorder: A Descriptive Study of Non-Treatment-Seeking Individuals
- Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients
- The lived experiences and treatment needs of women with opioid use disorder and posttraumatic stress symptoms: A mixed methods study of women and providers
- Levels of engagement among office-based opioid treatment (OBOT) patients with concurrent methamphetamine use
- Stepped Care for Patients to Optimize Whole Recovery (SC-POWR): An Effectiveness Trial Evaluating a Stepped Care Model for Individuals With Opioid Use Disorder and Chronic Pain
- How Financial Beliefs and Behaviors Influence the Financial Health of Individuals Struggling with Opioid Use Disorder
- Withdrawal catastrophizing scale: initial psychometric properties and implications for the study of opioid use disorder and hyperkatifeia
- Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review
- Genome-wide association study reveals multiple loci for analgesia and opioid consumption behaviors associated with heroin vulnerability in outbred rats
- Neuroimaging of opioid effects in humans across conditions of acute administration, chronic pain therapy, and opioid use disorder
- Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine
- Leveraging neuroscience education to address stigma related to opioid use disorder in the community: a pilot study
- Leveraging neuroscience education to address stigma related to opioid use disorder in the community: a pilot study
- Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review
- Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway
- Buprenorphine prescribing and treatment accessibility in response to regulation changes due to the COVID-19 public health emergency
- Outcomes of an Interprofessional Opioid Training Program for Graduate Students in Nursing and Social Work
- The Americans with Disabilities Act and Medication Assisted Treatment in Correctional Settings
- Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder
- Characterizing medical patients with delirium: A cohort study comparing ICD-10 codes and a validated chart review method
- Opioid use and risks in liver transplant candidates and recipients
- Provider-patient relationships and trauma among pregnant patients with opioid-use disorder
- Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach
- Comparison of Opioid Use Disorder Patients with and without Problematic Internet Use in Terms of Impulsivity and Attention Deficit Hyperactivity Disorder
- Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral Treatment
- Evaluation of heroin-assisted treatment in Norway: protocol for a mixed methods study
- The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients
- Buprenorphine Prescribing and Challenges Faced Among National Health Service Corps Clinicians
- Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial
- The sociodemographic profile and the challenges associated with treatment and rehabilitation in female heroin users: A case series from Northeast India
- The influence of familial networks and stigma on prison-based medication initiation for individuals with opioid use disorder: Clinicians' perceptions
- A pilot randomized controlled trial of medication adherence therapy: Psychosocial leverage using a significant other (MAT-PLUS) for individuals on extended-release naltrexone
- Model of negative affect induced by withdrawal from acute and chronic morphine administration in male mice
- Validation of an ICD-code-based case definition for psychotic illness across three health systems
- Wiidookaage'win: Beta-test of a Facebook group intervention for native women to support opioid use recovery
- Short- and long-term safety of discontinuing chronic opioid therapy among older adults with Alzheimer's disease and related dementia
- Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study
- Relationship-Oriented Recovery System for Youth (RORSY): Clinical Protocol for Transition-Age Youth with Opioid Use Disorders
- Relationship-Oriented Recovery System for Youth (RORSY): Clinical Protocol for Transition-Age Youth with Opioid Use Disorders
- Experiences of Stigma and Discrimination Compounded by Intersecting Identities among Individuals Receiving Medication for Opioid Use Disorder
- Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study
- Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study
- Access to Mental Health and Substance Use Treatment in Comprehensive Primary Care Plus
- Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up
- Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up
- Clinically defining the opioid-exposed birthing person and infant as a dyad to support bedside care, surveillance, and research
- Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada
- Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada
- An acute phase reaction from zoledronate mimicking symptoms seen in opioid withdrawal: a case report
- Practitioner perspectives on working with older patients in opioid agonist treatment (OAT) in Norway: opportunities and challenges
- Coding of Childhood Psychiatric and Neurodevelopmental Disorders in Electronic Health Records of a Large Integrated Health Care System: Validation Study
- Detecting DSM-5 Opioid and Methamphetamine Use Disorders With the UNCOPE Screen
- Patient and pharmacist perspectives on opioid misuse screening and brief interventions in community pharmacies
- Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder
- What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, Canada
- Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada
- Coding of Childhood Psychiatric and Neurodevelopmental Disorders in Electronic Health Records of a Large Integrated Health Care System: Validation Study
- Perceptions around medications for opioid use disorder among a diverse sample of U.S. adults
- Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes
- The development and internal validation of a multivariable model predicting 6-month mortality for people with opioid use disorder presenting to community drug services in England: a protocol
Evidence Blueprint
Validating opioid use disorder diagnoses in administrative data: a commentary on existing evidence and future directions
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Validating opioid use disorder diagnoses in administrative data: a commentary on existing evidence and future directions
🌐 365 Days
VR Related Evidence Matrix
- Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: Challenges and opportunities
- Identification of opioid use disorder using electronic health records: Beyond diagnostic codes
- Non-overdose acute care hospitalizations for opioid use disorder among commercially-insured adults: a retrospective cohort study
- Initiation of Extended-release Depot Buprenorphine in a Patient Subject to a Community Treatment Order for Both Antipsychotic and Opioid Agonist Treatments
- Opioid-induced hypogonadism in opioid use disorder, its role in negative reinforcement, and implications for treatment and retention
- Association between opioid use disorder and palliative care: a cohort study using linked health administrative data in Ontario, Canada
- Psychotherapies in opioid use disorder: toward a step-care model
- An Appraisal of Using Opioids in Patients with Opioid Use Disorder
- Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder
- Shaping and shifting schemas on supervised injectable opioid treatment: findings from a cross-sectional qualitative study in two German treatment facilities
- Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus
- Profiling neuronal methylome and hydroxymethylome of opioid use disorder in the human orbitofrontal cortex
- Buprenorphine and Opioid Use Disorder Training: Graduate Nursing Curricula Recommendations
- Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic
- Timing of treatment for opioid use disorder among birthing people
- The association of pain impact and sleep disruption with opioid withdrawal during opioid-use disorder treatment
- Exploring mental health comorbidities and opioid agonist treatment coverage among people in prison: A national cohort study 2010-2019
- The Perceived Role of Withdrawal in Maintaining Opioid Addiction among Adults with Untreated Opioid Use Disorder: A Survey of Syringe Exchange Program Participants
- Trends in maternal opioid use disorder and neonatal abstinence syndrome in Maine, 2016-2022
- Neuroimmune mechanisms of opioid use disorder and recovery: Translatability to human studies, and future research directions
- Transcriptional signatures of heroin intake and relapse throughout the brain reward circuitry in male mice
- Processing abnormalities in monetary outcome evaluations among male individuals with opioid use disorder: evidence from feedback-related negativity
- Mobile service delivery in response to the opioid epidemic in Philadelphia
- ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids
- Application of an opioid use disorder cascade of care in a large public health system
- Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals
- Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use
- Medical and genetic correlates of long-term buprenorphine treatment in the electronic health records
- "I wouldn't need Narcan for myself, but I can have it for somebody else:" perceptions of harm reduction among hospitalized patients with OUD
- Sleep Health Among Adults in Outpatient Opioid Use Disorder Treatment: A Systematic Review
- Assessing men with opioid use disorder for testosterone deficiency after the development of symptoms
- Pain and its Perceived Relatedness to the Onset, Maintenance, and Relapse of Opioid use Disorder: A Descriptive Study of Non-Treatment-Seeking Individuals
- Doing Our Best in a Broken System: The Urgent Need for Expansion of Medication for Opioid Use Disorder Treatments in the United States
- Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients
- Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder
- The lived experiences and treatment needs of women with opioid use disorder and posttraumatic stress symptoms: A mixed methods study of women and providers
- Levels of engagement among office-based opioid treatment (OBOT) patients with concurrent methamphetamine use
- Methylation and expression quantitative trait loci rs1799971 in the OPRM1 gene and rs4654327 in the OPRD1 gene are associated with opioid use disorder
- Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators
- Cognitive behavioral therapy for anxiety and opioid use disorder: Development and pilot testing
- Pain Management in Patients With Opioid Use Disorder on Extended-release Buprenorphine: A Case Report
- The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose
- Improving Translational Research Outcomes for Opioid Use Disorder Treatments
- Analysis of nonfatal suicide attempts and demographic characteristics of US military veterans with opioid use disorder: A descriptive VA medical center study
- Stepped Care for Patients to Optimize Whole Recovery (SC-POWR): An Effectiveness Trial Evaluating a Stepped Care Model for Individuals With Opioid Use Disorder and Chronic Pain
- Prevention of Opioid Use and Disorder Among Youth Involved in the Legal System: Innovation and Implementation of Four Studies Funded by the NIDA HEAL Initiative
- How Financial Beliefs and Behaviors Influence the Financial Health of Individuals Struggling with Opioid Use Disorder
- Hallucinogenic potential: a review of psychoplastogens for the treatment of opioid use disorder
- Cross-phenotype relationship between opioid use disorder and suicide attempts: new evidence from polygenic association and Mendelian randomization analyses
- Inequities in the treatment of opioid use disorder: A scoping review
- Emergency Department Access to Buprenorphine for Opioid Use Disorder
- Assessing Relapse in Patients with Opioid-Use Disorder and Chronic Non-Cancer Pain
- Digital Biomarker Applications Across the Spectrum of Opioid Use Disorder
- Buprenorphine: two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable form
- Withdrawal catastrophizing scale: initial psychometric properties and implications for the study of opioid use disorder and hyperkatifeia
- High Interest in Injectable Opioid Agonist Treatment With Hydromorphone Among Urban Syringe Service Program Participants
- Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial
- The role of co-occurring disorders in criminal recidivism and psychiatric recovery among adults with opioid use disorder and criminal-legal involvement: A statewide retrospective cohort study
- High-deductible Health Plans and Nonfatal Opioid Overdose
- Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process
- Patients' and Clinicians' Experiences with In-person, Video, and Phone Modalities for Opioid Use Disorder Treatment: A Qualitative Study
- Developing a Framework to Infer Opioid Use Disorder Severity From Clinical Notes to Inform Natural Language Processing Methods: Characterization Study
- Comparative Analysis of Instrumental Variables on the Assignment of Buprenorphine/Naloxone or Methadone for the Treatment of Opioid Use Disorder
- Genetic and non-genetic predictors of risk for opioid dependence